associ
viru
infect
acut
wheez
episod
recognis
decad
inde
wheez
cold
common
form
wheez
age
although
natur
debat
evolv
year
mani
old
chestnut
still
relev
year
includ
episod
virusinduc
wheez
young
children
consid
asthma
discuss
continu
whether
sever
earli
viru
infect
play
part
develop
asthma
immun
modul
andor
airway
damag
whether
children
present
virusinduc
wheez
preexist
predisposit
subject
becom
complic
sinc
recognis
earli
infect
may
protect
asthma
socal
hygien
hypothesi
sinc
acut
attack
relat
viru
infect
respons
great
deal
distress
wheezi
infant
children
asthma
treatment
condit
less
satisfactori
clearli
import
understand
mechan
respiratori
virus
trigger
wheez
also
preval
asthma
increas
recent
year
westernis
societi
necessari
understand
role
viru
infect
develop
asthma
could
implic
immunis
programm
expens
antivir
strategi
well
develop
new
approach
therapi
articl
attempt
put
issu
context
recent
publish
evid
review
subject
virus
implic
use
cultur
serolog
polymeras
chain
reaction
children
acut
wheez
exacerb
asthma
infant
common
culprit
respiratori
syncyti
viru
rsv
parainfluenza
viru
rhinovirus
account
major
episod
children
year
effect
host
defenc
infect
includ
virus
involv
product
type
cytokin
ifng
lymphocyt
infant
born
tendenc
respond
infect
produc
cytokin
profil
impair
respons
sinc
immun
respons
keyword
viru
wheez
asthma
child
summari
viral
infect
frequent
trigger
wheez
asthma
yet
role
develop
symptom
remain
controversi
preexist
airway
abnorm
contribut
earli
virusinduc
symptom
usual
remit
earli
childhood
wherea
interact
airway
inflamm
caus
exacerb
asthma
howev
distinct
two
group
reason
children
wheez
viral
infect
still
debat
effect
earli
infect
develop
immun
system
also
complex
success
matur
tcell
respons
predominantli
type
atop
predisposit
birth
predominantli
type
optim
viral
immun
respons
influenc
genet
factor
number
infect
known
affect
outcom
rel
part
play
predisposit
immunomodul
earli
infect
later
develop
asthma
still
controversi
content
gradual
resolv
detail
prospect
studi
elsevi
scienc
ltd
right
reserv
infect
also
involv
lymphocyt
probabl
appropri
label
respons
type
increas
matur
immun
respons
switch
predominantli
type
predominantli
type
respons
effect
repeat
infect
antigenpres
cell
produc
absenc
infect
atop
predisposit
switch
type
predominantli
type
respons
impair
fig
infant
experi
infect
rsv
children
recurr
rhinoviru
infect
minor
develop
airway
obstruct
wheez
still
matter
debat
virus
exampl
rsv
influenza
virus
actual
infect
lower
airway
potenti
caus
airway
obstruct
acut
inflammatori
process
rhinoviru
rna
found
bronchoalveolar
lavag
biopsi
sampl
inocul
volunt
signific
still
clear
number
mechan
identifi
could
contribut
airway
obstruct
increas
bronchial
respons
seen
associ
acut
viral
infect
asthma
lesser
extent
normal
subject
tabl
fig
recent
review
much
data
obtain
experiment
viral
infect
adult
mild
asthma
necessarili
histori
virusinduc
exacerb
normal
extent
process
may
vari
accord
host
immun
respons
presenc
absenc
underli
airway
inflamm
particular
viru
infect
involv
like
interact
addit
synergist
acut
viral
inflamm
asthma
patholog
particular
interest
possibl
preexist
airway
inflamm
could
interfer
host
antivir
defenc
skew
respons
toward
type
exagger
damag
airway
epidemiolog
viral
wheez
differ
wheez
phenotyp
identifi
accord
age
onset
durat
wheez
larg
birth
cohort
followup
studi
tucson
studi
influenti
studi
report
relat
symptom
viru
infect
scheme
provid
basi
consid
possibl
differ
known
children
group
experi
wheez
first
year
life
thereaft
transient
wheez
reduc
lung
function
increas
bronchial
respons
prior
respiratori
ill
predispos
airway
dysfunct
reduc
airway
calibr
andor
alter
mechan
also
associ
matern
smoke
pregnanc
howev
transient
wheez
also
occur
whose
mother
never
smoke
suggest
addit
prenat
environment
genet
influenc
exampl
polymorph
receptor
gene
recent
shown
influenc
neonat
lung
function
bronchial
respons
associ
symptom
viru
infect
transient
wheez
establish
origin
studi
often
assum
due
common
observ
young
children
recurr
virusinduc
wheez
grow
symptom
first
year
also
virus
detect
major
acut
episod
young
well
older
children
transient
wheez
ie
remit
birthday
may
one
condit
typic
young
children
respond
poorli
bronchodil
corticosteroid
therapi
month
age
keep
mechan
basi
symptom
continu
exhibit
episod
viral
wheez
without
chang
symptom
pattern
begin
respond
unequivoc
bronchodil
know
infant
function
beta
receptor
protect
induc
bronchoconstrict
month
age
possibl
two
independ
airway
defect
one
relat
reduc
airway
calibr
possibl
matern
smoke
alter
tone
could
result
reduc
lung
function
birth
possibl
genet
basi
dysfunct
airway
tone
increas
respons
bronchodil
associ
polymorph
adrenoceptor
amino
acid
genotyp
relat
reduc
lung
function
increas
bronchial
respons
birth
turn
found
transient
wheez
like
overlap
transient
wheez
group
episod
wheezer
describ
disord
airway
tone
also
suggest
condit
rather
ill
defin
may
correspond
categori
tucson
studi
remit
age
year
children
show
increas
daili
peak
flow
variabl
suggest
abnorm
airway
dynam
unrel
atopi
contrast
atop
persist
wheezer
characterist
classic
asthma
children
improv
later
childhood
also
tucson
followup
studi
children
rsv
infect
earli
life
continu
increas
risk
episod
wheez
age
year
number
diminish
age
children
show
reduc
prebut
postbronchodil
lung
function
neither
studi
took
account
pattern
symptom
could
repres
sort
schoolag
children
wheez
sole
relat
viral
infect
whose
symptom
respond
inhal
beclomethason
taken
togeth
studi
suggest
group
children
wheez
associ
recurr
viral
infect
independ
atopi
abnorm
airway
tone
support
genet
basi
type
wheez
sole
relat
infect
provid
famili
studi
children
wheezi
bronchiti
exactli
viru
infect
induc
revers
bronchoconstrict
situat
clear
unlik
mediat
via
chronic
eosinophil
airway
inflammatori
process
lack
respons
inhal
corticosteroid
eosinophil
found
bronchoalveolar
lavag
children
symptom
associ
viru
infect
fig
virusinduc
attack
atop
asthma
children
asthma
develop
attack
associ
viral
infect
commonli
upper
respiratori
tract
rhinoviru
number
mechan
implic
tabl
fig
infant
subsequ
develop
persist
wheez
show
mark
eosinophil
respons
initi
viral
infect
compar
transient
wheez
indic
differ
two
group
immun
respons
viru
infect
occur
even
infanc
even
though
clinic
pictur
may
ident
asthma
consequ
acut
viral
infect
includ
necessari
harm
effect
viru
elimin
addit
possibl
interact
amplif
airway
inflamm
tabl
fig
also
type
skew
immun
respons
could
result
delay
viral
clearanc
prolong
viral
inflamm
although
sequenc
event
clearli
understood
process
would
contribut
virusinduc
airway
obstruct
increas
bronchial
respons
paradox
concern
role
virus
atop
diseas
one
hand
indic
protect
effect
earli
viral
infect
hand
view
respiratori
viral
infect
increas
likelihood
asthma
topic
subject
extens
recent
review
evid
rsv
bronchiol
damag
grow
lung
alter
immun
respons
debat
whether
sever
earli
respiratori
viral
infect
damag
grow
lung
enhanc
atop
sensitis
continu
least
two
decad
argument
mainli
focus
children
hospitalis
rsv
bronchiol
howev
discuss
definit
extrem
import
term
bronchiol
asthma
still
use
loos
way
mislead
rsv
implic
incept
recurr
wheez
first
wheez
episod
child
year
typic
sever
airway
obstruct
refer
rsvinfect
wheezi
episod
age
year
immunomodul
rsv
infect
postul
see
subsequ
wheez
call
asthma
unless
associ
atopi
type
skew
immun
respons
larg
number
studi
shown
recurr
wheez
markedli
increas
follow
rsv
bronchiol
least
year
increas
wheez
episod
occur
age
year
children
rsvposit
infect
infanc
treat
commun
suggest
sever
necessari
factor
featur
children
postbronchiolit
wheez
reduc
lung
function
increas
bronchial
respons
compar
control
followup
question
whether
due
preexist
abnorm
caus
predisposit
wheez
whether
structur
airway
damag
secondari
initi
rsv
infect
find
lung
function
bronchial
respons
increas
children
transient
wheez
prior
first
wheezi
episod
strongli
support
predisposit
concept
next
contenti
issu
whether
rsv
infect
influenc
allerg
sensitis
immunomodul
increas
likelihood
atopi
therefor
asthma
develop
strict
entri
criteria
use
defin
rsv
bronchiol
exclud
children
year
entri
rsv
infect
confirm
first
wheezi
episod
review
elig
studi
conclud
postbronchiolit
wheez
associ
increas
risk
atopi
famili
histori
atopi
make
immunomodul
rsv
infect
unlik
one
glare
except
studi
sigur
et
al
rsv
bronchiol
strongest
independ
risk
factor
asthma
atop
sensitis
multivari
analysi
author
defin
asthma
occurr
least
three
episod
wheez
exclud
continu
recurr
viral
wheez
patholog
ground
would
also
includ
asthma
surpris
asthma
definit
predict
rsv
infect
studi
use
match
control
enrol
contemporan
ie
rsv
epidem
surprisingli
wheez
followup
neither
anyon
famili
histori
asthma
rsv
bronchiol
anoth
interpret
find
failur
develop
bronchiol
rsv
epidem
neg
risk
factor
develop
asthma
allergi
select
control
bias
develop
asthma
subsequ
immunolog
differ
rsv
group
would
similarli
skew
normal
host
respons
viru
infect
predominantli
type
respons
secret
ifng
fig
strongest
evid
causal
link
rsv
bronchiol
develop
asthma
induct
atop
sensitis
come
anim
studi
firstli
guinea
pig
rat
type
respons
demonstr
follow
rsv
infect
howev
type
respons
mainli
seen
formalininactiv
virus
use
studi
mice
shown
viral
infect
interact
inhal
allergen
promot
develop
airway
inflamm
atop
sensitis
human
infant
type
skew
respons
indic
low
ifng
rel
rais
level
peripher
monocyt
blood
cell
rsvinfect
infant
could
repres
increas
suscept
rsv
infect
preexist
impair
type
respons
type
skew
respons
could
result
infect
latter
support
find
increas
stimul
monocyt
convalesc
rsv
bronchiol
children
went
recurr
episod
wheez
number
subsequ
wheez
episod
correl
convalesc
valu
sinc
differ
found
acut
phase
suggest
virusinduc
chang
cytokin
respons
whether
translat
atop
asthma
still
determin
oppos
view
indic
studi
one
show
lower
cord
blood
suggest
impair
type
immun
subsequ
bronchiol
fig
anoth
studi
show
reduc
type
cytokin
associ
sever
rsv
diseas
reinterpret
followup
studi
infant
rsv
sigur
et
al
see
compat
line
argument
preexist
type
skew
immun
occur
develop
rsv
bronchiol
line
argument
reinforc
find
associ
polymorph
sever
rsv
bronchiol
furthermor
although
adult
atop
asthma
increas
risk
rhinoviru
infect
shown
experi
frequent
sever
lower
respiratori
tract
symptom
unifi
explan
suggest
genet
variat
pattern
recognit
receptor
may
influenc
clinic
express
viral
diseas
develop
allergi
question
whether
rsv
infect
uniqu
among
virus
associ
subsequ
increas
recurr
wheez
studi
compar
outcom
infant
hospitalis
rsvposit
neg
lower
respiratori
tract
infect
bronchiol
found
differ
two
use
polymeras
chain
reaction
rhinoviru
implic
case
bronchiol
possibl
noth
specif
rsv
apart
fact
common
caus
sever
lower
respiratori
tract
infect
infanc
overal
convinc
evid
preexist
type
predisposit
failur
matur
toward
type
fig
lead
sever
rsv
infect
destin
develop
asthma
howev
airway
damag
caus
addit
lung
function
deficit
exclud
induct
exagger
type
respons
children
also
remain
possibl
transient
increas
lung
function
bronchial
respons
shown
anim
model
normal
human
volunt
clinic
artifici
induc
upper
respiratori
viral
infect
asthma
increas
mark
increas
sensit
maxim
respons
constrictor
agent
detect
subject
mani
mechan
associ
acut
viral
inflamm
tabl
fig
would
expect
increas
bronchial
respons
turn
like
part
virusinduc
asthma
exacerb
viru
host
characterist
probabl
determin
size
respons
reduc
lung
function
presenc
atopi
increas
effect
recent
studi
virusinduc
lower
airway
chang
adult
without
asthma
inocul
coronaviru
histori
viral
wheez
show
greater
degre
cold
symptom
greater
fall
fev
larger
increas
bronchial
respons
without
histori
effect
atopi
seen
differ
baselin
measur
yet
unidentifi
addit
factor
suggest
infrequ
argu
rsv
infect
infant
induc
prolong
state
increas
bronchial
respons
respons
subsequ
increas
recurr
wheez
howev
never
demonstr
furthermor
increas
bronchial
respons
found
first
viral
infect
transient
wheez
evid
earli
viral
infect
protect
later
develop
asthma
subject
arous
much
interest
past
year
find
effect
birth
order
famili
size
surrog
marker
infect
load
develop
allergi
protect
role
infect
also
seen
develop
countri
invers
relationship
evid
respiratori
infect
serolog
actual
infect
measl
later
develop
atopi
found
one
possibl
find
could
result
genet
bia
confin
commun
unlik
similarli
reduc
preval
atop
diseas
east
germani
compar
genet
similar
popul
west
germani
east
german
children
assum
expos
infect
much
greater
use
earli
daycar
associ
less
subsequ
asthma
howev
paradox
sever
studi
show
parent
report
lower
respiratori
ill
posit
associ
later
asthma
littl
discuss
reason
possibl
confus
variat
definit
asthma
use
immun
modul
consid
factor
develop
asthma
two
uncommon
definit
flaw
occurr
three
wheezi
episod
wheez
beyond
year
firstli
children
transient
wheez
often
experi
three
episod
therefor
could
definit
wrongli
categoris
asthma
secondli
children
recurr
wheez
follow
rsv
infect
independ
atopi
may
remit
year
explan
appar
paradox
put
forward
mallia
et
al
daycar
use
larg
famili
size
reflect
increas
viral
load
includ
gastrointestin
virus
independ
host
respons
contrast
parent
report
symptom
reflect
host
respons
children
destin
asthma
impair
type
respons
viru
infect
therefor
risk
frequent
sever
symptom
like
report
adult
studi
design
avoid
report
bia
asthma
control
number
upper
respiratori
infect
assess
polymeras
chain
reaction
asthma
report
lower
respiratori
symptom
support
line
reason
illi
et
al
show
repeat
viral
infect
earli
life
lower
respiratori
tract
protect
asthma
explan
hygien
hypothesi
propos
viral
infect
infanc
induc
acut
wheez
episod
promot
develop
type
tcell
respons
fig
absenc
infect
default
type
skew
respons
present
birth
persist
result
increas
risk
sensitis
aeroallergen
theori
base
studi
show
differ
immun
respons
first
respiratori
infect
infant
subsequ
develop
persist
wheez
asthma
transient
wheez
independ
type
viru
implic
young
children
wheez
initi
present
episod
relat
viral
infect
small
proport
order
continu
wheez
later
childhood
consid
asthma
first
year
life
clinic
indistinguish
children
transient
wheez
longstand
aim
clinician
predict
asthma
later
theori
antiinflammatori
treatment
given
earli
could
modifi
outcom
popul
studi
risk
factor
person
atopi
famili
histori
asthma
use
provid
rel
risk
develop
asthma
reason
accuraci
use
individu
approach
insuffici
sensit
sinc
type
skew
respons
increas
ige
rel
eosinophilia
rais
secp
infect
seen
infant
destin
persist
wheez
inform
obtain
blood
test
initi
episod
potenti
predict
use
howev
inform
unlik
avail
routin
find
rsvspecif
ige
rsv
bronchiol
correl
subsequ
wheez
episod
age
year
symptom
atopi
thereaft
one
way
viru
infect
could
perpetu
symptom
chronic
latent
infect
doublestrand
dna
virus
abil
persist
airway
epitheli
cell
long
acut
infect
resolv
latent
infect
viral
gene
express
without
viral
replic
latent
adenoviru
shown
human
anim
airway
epithelium
ninetyfour
percent
children
steroidresist
asthma
control
found
adenoviru
antigen
airway
littl
attent
paid
symptom
specif
relat
viru
infect
except
acut
rsv
bronchiol
beyond
scope
articl
acut
wheez
episod
associ
viral
infect
preexist
abnorm
lung
function
occur
episod
viral
wheez
increas
viral
load
protect
asthma
immunomodul
children
predomin
type
respons
atop
sever
lower
respiratori
infect
longitudin
birth
cohort
studi
relat
immun
statu
respons
infect
respiratori
outcom
therapeut
trial
consid
efficaci
antiinflammatori
agent
virusinduc
symptom
asthma
investig
children
wheez
other
respons
viru
infect
therapi
direct
viral
wheez
use
recent
knowledg
mechan
rhinoviru
patholog
